Positron Emission Tomography?Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F11%3A00053032" target="_blank" >RIV/00216224:14110/11:00053032 - isvavai.cz</a>
Alternative codes found
RIV/65269705:_____/11:#0001363
Result on the web
<a href="http://dx.doi.org/10.1200/JCO.2011.35.0736" target="_blank" >http://dx.doi.org/10.1200/JCO.2011.35.0736</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1200/JCO.2011.35.0736" target="_blank" >10.1200/JCO.2011.35.0736</a>
Alternative languages
Result language
angličtina
Original language name
Positron Emission Tomography?Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants
Original language description
The utility of [18F]fluorodeoxyglucose (FDG) positron emission tomography?computed tomography (PET-CT) in assessing response at the end of induction therapy is well documented in Hodgkin's and diffuse large B-cell lymphomas, but its role in follicular lymphoma (FL) remains undetermined. We investigated the prognostic significance of PET-CT performed after first-line therapy in patients with FL treated in the prospective Primary Rituximab and Maintenance (PRIMA) study. Results of PET-CT scans performed after induction immunochemotherapy were recorded retrospectively. Patients went on to either observation or rituximab maintenance per protocol independent of the PET-CT result. Patient characteristics and outcomes were then evaluated. Of 122 PET-CT scansperformed at the end of the induction immunochemotherapy, 32 (26%) were reported as positive by the local investigator.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2011
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Journal of Clinical Oncology
ISSN
0732-183X
e-ISSN
—
Volume of the periodical
29
Issue of the periodical within the volume
23
Country of publishing house
US - UNITED STATES
Number of pages
7
Pages from-to
3194-3200
UT code for WoS article
000293628400021
EID of the result in the Scopus database
—